BioVie Inc. Faces Multiple Class Action Lawsuits Ahead of March Deadline

Investors urged to join lawsuits alleging false statements and oversight failures in clinical trials.

Rosen Law Firm reminds BioVie Inc. investors of the March 19, 2024, lead plaintiff deadline in a class action lawsuit.
Investors in BioVie Inc. are encouraged to contact Levi & Korsinsky before March 19, 2024, to discuss their rights regarding a class action lawsuit.
Bronstein, Gewirtz & Grossman, LLC notifies BioVie Inc. investors of a class action lawsuit and encourages them to join the case.
The lawsuits allege BioVie Inc. made false statements and failed to disclose adverse facts about its business operations and prospects.
Claims focus on the impact of COVID-19 on clinical trials, leading to potential protocol violations and unreliable data.